`
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`————————————————
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`————————————————
`
`ACRUX DDS PTY LTD., ACRUX LIMITED, and
`ARGENTUM PHARMACEUTICALS LLC,
`Petitioners
`
`v.
`
`KAKEN PHARMACEUTICAL CO., LTD. and
`VALEANT PHARMACEUTICALS INTERNATIONAL, INC.
`Patent Owners.
`————————————————
`
`Case: IPR2017-00190
`U.S. Patent No. 7,214,506
`
`————————————————
`
`ACRUX’S UNOPPOSED
`MOTION FOR PRO HAC VICE ADMISSION OF
`JOSEPH T. JAROS PURSUANT TO 37 C.F.R. § 42.10(C)
`
`
`
`
`
`I.
`
`RELIEF REQUESTED.
`
`
`
`Pursuant to 37 C.F.R. § 42.10(c) authorizing motions for pro hac vice
`
`admission of back-up counsel, Petitioners Acrux DDS Pty Ltd. and Acrux Limited
`
`(“Acrux”) request that the Board admit Joseph T. Jaros pro hac vice in this
`
`proceeding, IPR2017-00190. Counsel for Acrux have met and conferred with
`
`counsel for Patent Owner, and Patent Owner does not oppose this motion.
`
`II.
`
`STATEMENT OF FACTS.
`
`Pursuant to 37 C.F.R. § 42.10(c), the Board
`
`may recognize counsel pro hac vice during a proceeding upon a
`showing of good cause, subject to the condition that lead counsel be a
`registered practitioner and to any other conditions as the Board may
`impose. For example, where the lead counsel is a registered
`practitioner, a motion to appear pro hac vice by counsel who is not a
`registered practitioner may be granted upon showing that counsel is an
`experienced litigating attorney and has an established familiarity with
`the subject matter at issue in the proceeding.
`
`37 C.F.R. § 42.10(c). The facts, supported by the attached Declaration of Joseph
`
`T. Jaros in Support of Motion for Admission Pro Hac Vice (Exhibit A) (“Jaros
`
`Decl.”), establish good cause to recognize Mr. Jaros pro hac vice in this
`
`proceeding.
`
`1.
`
`Lead counsel Tara M. Raghavan is a registered practitioner before the
`
`USPTO.
`
`2.
`
`Back-up counsel Steven J. Birkos is a registered practitioner before
`
`the USPTO.
`
`
`
`
`
`
`
`3.
`
`Joseph T. Jaros is an experienced litigating attorney. Mr. Jaros has
`
`been a litigating attorney for more than 18 years. (Jaros Decl. ¶ 1). Mr. Jaros has
`
`been litigating patent cases for over 10 years. (Id. ¶ 2). Mr. Jaros is a member in
`
`good standing of the Illinois State Bar and Colorado State Bar, with no suspensions
`
`or disbarments from practice, nor any application for admission to practice denied,
`
`nor any sanctions or contempt citations, and is admitted to practice in the United
`
`States Court of Appeals for the Federal Circuit, the United States District Courts
`
`for the Northern District of Illinois and the District of Colorado. (Id. ¶¶ 3-6).
`
`4. Mr. Jaros has familiarity with the subject matter at issue in this
`
`proceeding and, more specifically, he is familiar with the patent at issue in this
`
`proceeding—U.S. Patent No. 7,214,506 (“the ‘506 patent”). (Jaros Decl. ¶ 7). Mr.
`
`Jaros is currently advising Acrux on patent matters relating to the subject matter
`
`claimed in the patent at issue in this proceeding. (Id.). Mr. Jaros has become
`
`intimately familiar with the subject matter of the ‘506 patent and the prior art
`
`raised in the Petition. (Id.).
`
`5. Mr. Jaros has read and will comply with the Office Patent Trial
`
`Practice Guide and the Board’s Rules for Practice for Trials set forth in part 42 of
`
`the C.F.R, and he agrees to be subject to the USPTO Code of Professional
`
`Responsibility set forth in 37 C.F.R. §§11.101 et seq., and to disciplinary
`
`jurisdiction under 37 C.F.R. §11.19(a). (Jaros Decl. ¶¶ 8-9).
`
`
`
`2
`
`
`
`III. ANALYSIS.
`
`The facts contained in the Statement of Facts above, and contained in the
`
`Jaros Declaration, establish that there is good cause to admit Mr. Jaros pro hac vice
`
`in this proceeding under 37 C.F.R. §42.10(c). Lead and backup counsel are
`
`registered practitioners, Mr. Jaros is an experienced litigating attorney, and Mr.
`
`Jaros has an established familiarity with the subject matter at issue in the
`
`proceeding. Admission of Mr. Jaros will further enable Acrux to be effectively
`
`and efficiently represented before the Board in this proceeding, and in other
`
`matters relating to the same subject areas. Lead and backup counsel will ensure
`
`that Mr. Jaros follows the rules as set out by the Board.
`
`IV. CONCLUSION.
`
`For the foregoing reasons, Acrux respectfully requests that the Board admit
`
`Joseph T. Jaros pro hac vice in this proceeding.
`
`
`
`Dated: September 25, 2018
`
`By:
`
`Respectfully submitted,
`
`/s/ Tara M. Raghavan
`Tara M. Raghavan, Reg. No. 55,557
`RAKOCZY MOLINO MAZZOCHI SIWIK LLP
`6 W. Hubbard Street, Suite 500
`Chicago, Illinois 60654
`Telephone: (312) 222-6340
`Facsimile: (312) 222-6341
`
`Counsel for Acrux DDS Pty Ltd. and Acrux
`Limited
`
`
`
`3
`
`
`
`
`
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`The undersigned hereby certifies that a true and correct copy of the
`
`foregoing Acrux’s Unopposed Motion for Pro Hac Vice Admission of Joseph T.
`
`Jaros Pursuant to 37 C.F.R. § 42.10(c) was served on September 25, 2018, via
`
`electronic mail by agreement of the parties, on the following:
`
`John D. Livingstone
`Finnegan, Henderson, Farabow, Garret & Dunner, L.L.P.
`271 17th Street, NW, Suite 1400
`Atlanta, GA 30363-6209
`john.livingstone@finnegan.com
`KakenIPR@finnegan.com
`
`Naoki Yoshida
`naoki.yoshida@finnegan.com
`Anthony Hartmann
`anthony.hartmann@finnegan.com
`Barbara R. Rudolph, Ph.D.
`barbara.rudolph@finnegan.com
`Finnegan, Henderson, Farabow, Garret & Dunner, L.L.P.
`901 New York Ave., NW
`Washington, DC 20001-4413
`
`Toan P. Vo
`toan.vo@bausch.com
`Valeant Pharmaceuticals North America LLC
`1400 N. Goodman Street
`Rochester, New York 14609
`
`Teresa Staneck Rea
`TRea@Crowell.com
`Shannon M. Lentz
`SLentz@Crowell.com
`Crowell & Moring LLP
`Intellectual Property Group
`1001 Pennsylvania Ave, NW
`
`
`
`
`
`
`
`Washington, DC 2004-2595
`
`Tyler C. Liu
`TLiu@agpharm.com
`Argentum Pharmaceuticals, LLC
`
`
`
`
`
`Dated: September 25, 2018
`
`By:
`
`
`
`
`
`
`
`
`Respectfully submitted,
`
`/s/ Tara M. Raghavan
`Tara M. Raghavan, Reg. No. 55,557
`Rakoczy Molino Mazzochi Siwik LLP
`6 W. Hubbard Street, Suite 500
`Chicago, Illinois 60654
`Telephone: (312) 222-6340
`Facsimile: (312) 222-6341
`
`Counsel for Acrux DDS Pty Ltd. and Acrux
`Limited
`
`2
`
`